Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib

Detalles Bibliográficos
Autores principales: Harrington, Patrick, Doores, Katie J., Saunders, Jamie, de Lord, Marc, Saha, Chandan, Lechmere, Thomas, Khan, Hataf, Lam, Ho Pui Jeff, Reilly, Amy O’, Woodley, Claire, Asirvatham, Susan, Dillon, Richard, Curto-Garcia, Natalia, Sullivan, Jennifer O’, Kordasti, Shahram, Raj, Kavita, Malim, Michael H., Radia, Deepti, McLornan, Donal, Harrison, Claire, de Lavallade, Hugues
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024068/
https://www.ncbi.nlm.nih.gov/pubmed/35459222
http://dx.doi.org/10.1038/s41408-022-00651-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024068/
https://www.ncbi.nlm.nih.gov/pubmed/35459222
http://dx.doi.org/10.1038/s41408-022-00651-3

Ejemplares similares